337 related articles for article (PubMed ID: 32231741)
1. Histone methyltransferase SETD2: a potential tumor suppressor in solid cancers.
Chen R; Zhao WQ; Fang C; Yang X; Ji M
J Cancer; 2020; 11(11):3349-3356. PubMed ID: 32231741
[TBL] [Abstract][Full Text] [Related]
2. Structure/Function Analysis of Recurrent Mutations in SETD2 Protein Reveals a Critical and Conserved Role for a SET Domain Residue in Maintaining Protein Stability and Histone H3 Lys-36 Trimethylation.
Hacker KE; Fahey CC; Shinsky SA; Chiang YJ; DiFiore JV; Jha DK; Vo AH; Shavit JA; Davis IJ; Strahl BD; Rathmell WK
J Biol Chem; 2016 Sep; 291(40):21283-21295. PubMed ID: 27528607
[TBL] [Abstract][Full Text] [Related]
3. The Benzene Hematotoxic and Reactive Metabolite 1,4-Benzoquinone Impairs the Activity of the Histone Methyltransferase SET Domain Containing 2 (SETD2) and Causes Aberrant Histone H3 Lysine 36 Trimethylation (H3K36me3).
Berthelet J; Michail C; Bui LC; Le Coadou L; Sirri V; Wang L; Dulphy N; Dupret JM; Chomienne C; Guidez F; Rodrigues-Lima F
Mol Pharmacol; 2021 Sep; 100(3):283-294. PubMed ID: 34266924
[TBL] [Abstract][Full Text] [Related]
4. SETD2-H3K36ME3: an important bridge between the environment and tumors.
He J; Xu T; Zhao F; Guo J; Hu Q
Front Genet; 2023; 14():1204463. PubMed ID: 37359376
[TBL] [Abstract][Full Text] [Related]
5. Roles of SETD2 in Leukemia-Transcription, DNA-Damage, and Beyond.
Skucha A; Ebner J; Grebien F
Int J Mol Sci; 2019 Feb; 20(5):. PubMed ID: 30818762
[TBL] [Abstract][Full Text] [Related]
6. Histone methyltransferase SETD2: An epigenetic driver in clear cell renal cell carcinoma.
Yu M; Qian K; Wang G; Xiao Y; Zhu Y; Ju L
Front Oncol; 2023; 13():1114461. PubMed ID: 37025591
[TBL] [Abstract][Full Text] [Related]
7. SETD2, an epigenetic tumor suppressor: a focused review on GI tumor.
Hu M; Hu M; Zhang Q; Lai J; Liu X
Front Biosci (Landmark Ed); 2020 Jan; 25(4):781-797. PubMed ID: 31585917
[TBL] [Abstract][Full Text] [Related]
8. SETD2 as a regulator of N6-methyladenosine RNA methylation and modifiers in cancer.
Kumari S; Muthusamy S
Eur J Cancer Prev; 2020 Nov; 29(6):556-564. PubMed ID: 33021769
[TBL] [Abstract][Full Text] [Related]
9. SETD2: an epigenetic modifier with tumor suppressor functionality.
Li J; Duns G; Westers H; Sijmons R; van den Berg A; Kok K
Oncotarget; 2016 Aug; 7(31):50719-50734. PubMed ID: 27191891
[TBL] [Abstract][Full Text] [Related]
10. SETD2: from chromatin modifier to multipronged regulator of the genome and beyond.
Molenaar TM; van Leeuwen F
Cell Mol Life Sci; 2022 Jun; 79(6):346. PubMed ID: 35661267
[TBL] [Abstract][Full Text] [Related]
11. SETting the Stage for Cancer Development: SETD2 and the Consequences of Lost Methylation.
Fahey CC; Davis IJ
Cold Spring Harb Perspect Med; 2017 May; 7(5):. PubMed ID: 28159833
[TBL] [Abstract][Full Text] [Related]
12. Structural and enzymatic evidence for the methylation of the ACK1 tyrosine kinase by the histone lysine methyltransferase SETD2.
Le Coadou L; Berthelet J; Mechaly AE; Michail C; Bui LC; Dairou J; Haouz A; Dupret JM; Rodrigues Lima F
Biochem Biophys Res Commun; 2024 Feb; 695():149400. PubMed ID: 38160530
[TBL] [Abstract][Full Text] [Related]
13. The histone methyltransferase SETD2 negatively regulates cell size.
Molenaar TM; Malik M; Silva J; Liu NQ; Haarhuis JHI; Ambrosi C; Kwesi-Maliepaard EM; van Welsem T; Baubec T; Faller WJ; van Leeuwen F
J Cell Sci; 2022 Oct; 135(19):. PubMed ID: 36052643
[TBL] [Abstract][Full Text] [Related]
14. Functional Studies on Primary Tubular Epithelial Cells Indicate a Tumor Suppressor Role of SETD2 in Clear Cell Renal Cell Carcinoma.
Li J; Kluiver J; Osinga J; Westers H; van Werkhoven MB; Seelen MA; Sijmons RH; van den Berg A; Kok K
Neoplasia; 2016 Jun; 18(6):339-46. PubMed ID: 27292023
[TBL] [Abstract][Full Text] [Related]
15. The histone methyltransferase SETD2 is required for expression of acrosin-binding protein 1 and protamines and essential for spermiogenesis in mice.
Zuo X; Rong B; Li L; Lv R; Lan F; Tong MH
J Biol Chem; 2018 Jun; 293(24):9188-9197. PubMed ID: 29716999
[TBL] [Abstract][Full Text] [Related]
16. High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma.
Ho TH; Park IY; Zhao H; Tong P; Champion MD; Yan H; Monzon FA; Hoang A; Tamboli P; Parker AS; Joseph RW; Qiao W; Dykema K; Tannir NM; Castle EP; Nunez-Nateras R; Teh BT; Wang J; Walker CL; Hung MC; Jonasch E
Oncogene; 2016 Mar; 35(12):1565-74. PubMed ID: 26073078
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms in governing genomic stability and tumor suppression by the SETD2 H3K36 methyltransferase.
Lam UTF; Chen ES
Int J Biochem Cell Biol; 2022 Mar; 144():106155. PubMed ID: 34990836
[TBL] [Abstract][Full Text] [Related]
18. Histone Methyltransferase SETD2 Is Required for Porcine Early Embryonic Development.
Shao W; Ning W; Liu C; Zou Y; Yao Y; Kang J; Cao Z
Animals (Basel); 2022 Aug; 12(17):. PubMed ID: 36077946
[TBL] [Abstract][Full Text] [Related]
19. SETD2 alterations and histone H3K36 trimethylation in phyllodes tumor of breast.
Tsang JY; Lai ST; Ni YB; Shao Y; Poon IK; Kwan JS; Chow C; Shea KH; Tse GM
Breast Cancer Res Treat; 2021 Jun; 187(2):339-347. PubMed ID: 33844099
[TBL] [Abstract][Full Text] [Related]
20. Cryo-EM structure of SETD2/Set2 methyltransferase bound to a nucleosome containing oncohistone mutations.
Liu Y; Zhang Y; Xue H; Cao M; Bai G; Mu Z; Yao Y; Sun S; Fang D; Huang J
Cell Discov; 2021 May; 7(1):32. PubMed ID: 33972509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
